Pay in 4 interest-free payments of $7.00 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Medical and Pharmacologic Strategies New research from the American Diabetes Association has announced promising results from studies on combination therapies aimed at specifically preserving muscle mass during weight loss
In November 2023, the FDA approved a weight loss version of the drug, called Zepbound, which also contains tirzepatide
[1] [4] Kidney Problems : Notify your provider if you experience decreased urination, swelling in legs or feet, or unusual fatigue, as these may indicate kidney function changes, particularly in the setting of dehydration from gastrointestinal adverse effects
Keep the vial in its original packaging when not in use
[1] [2] A higher dose formulation of semaglutide (Wegovy) is licensed for weight management
